You just read:

Rheumatologists Agree That the American College of Rheumatology (ACR) 50/70 Clinical End Points Are More Persuasive than ACR 20 When Prescribing a New Drug for Psoriatic Arthritis

News provided by

Decision Resources Group

Apr 30, 2014, 10:00 ET